10X Fund, L.P. 4
4 · GALECTIN THERAPEUTICS INC · Filed Oct 15, 2019
Insider Transaction Report
Form 4
10X Fund, L.P.
10% Owner
Transactions
- Other
Common Stock
2019-08-02−38,690→ 6,402,790 total - Sale
Common Stock
2019-10-10$3.73/sh−17,000$63,325→ 6,385,790 total
Footnotes (3)
- [F1]10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
- [F2]Shares sold pursuant to 10X Fund, LP's Quarterly Liquidity Program.
- [F3]Shares were distributed in an in-kind distribution to a withdrawing limited partner of 10X Fund, LP of his pro rata share of shares held by 10X Fund, LP, which did not receive any consideration for the transfer. The distribution is exempt from Section 16(b) because it does not constitute a sale of a security pursuant to applicable law.